Navigation Links
Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
Date:12/4/2012

c type or that due to lupus erythematosus."  Questcor has also launched a pilot effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Dermatomyositis, Polymyositis, Lupus and Rheumatoid Arthritis. Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.    For more information about Questcor, please visit www.questcor.com.

Note: Except for the historical information contained herein, this press release contains forward-looking statements that have been made pursuant to the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "believes," "continue," "could," "estimates," "expects," "growth," "may," "plans," "potential," "should," "substantial" or "will" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Our reliance on Acthar for substantially all of our net sales and profits;
  • Research and development risks and our reliance on third-parties to conduct research and development and the ability of research and development to generate successful results;
  • Our ability to receive high reimbursement levels from third party payers;
  • Our ability to comply with federal and state regulations, including regulations relating to pharmaceutical sales and marketing practices;
  • The results of any pending or future litigation, investigations or claims, inclu
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
2. Questcor to Report Second Quarter Results on July 24, 2012
3. Questcor Reports Second Quarter Financial Results
4. Questcor Pharmaceuticals to Present at Investor Conferences in September
5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
(Date:3/27/2015)... 27, 2015 The International Myeloma Foundation (IMF) ... while working toward prevention and a cure – today ... a federal resolution (H. Res. 174) that supports the ... Multiple Myeloma Awareness Month." Currently there are ... more than 110,000 new cases are diagnosed yearly, according ...
(Date:3/27/2015)... DALLAS , March 27, 2015 ... Review, H1 2015" therapeutic market research report of ... to its online business intelligence library. ... comprehensive information on the therapeutic development for Visceral ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... 2012  Michael Volkov has joined the law firm of ... will be resident in the firm,s Alexandria, Va. and ... and veteran white collar defense attorney will provide compliance, ... broad range of issues, including the Foreign Corrupt Practices ...
... today that their applications for Transvaginal Mesh cases and ... company began funding plaintiffs for Mesh cash advances beginning ... industry do not fund Vaginal Mesh or Hernia Mesh ... is one of the few companies now offering plaintiffs ...
Cached Medicine Technology:Veteran FCPA and White Collar Attorney Michael Volkov Joins LeClairRyan 2Vaginal Mesh and Kugel Hernia Mesh Case Applications for Lawsuit Funding on the Rise at Legal-Bay Settlement Funding 2
(Date:3/27/2015)... Dallas, TX (PRWEB) March 27, 2015 ... Landscape – Germany” is an essential source of ... and reimbursement landscape in Germany. Germany’s increasingly elderly ... drivers of its pharmaceutical market. In 2013, the ... expected to increase at Compound Annual Growth Rate ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 DrugDev announced ... (Liss) Easy was named to the 2015 Philadelphia Business ... 40 list spotlights 40 dynamic, up-and-coming leaders less than ... community involvement. Winners are honored at an awards program ... the Philadelphia Business Journal. , Lyn Kremer, Publisher of ...
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... California’s ongoing worst ever drought, and ... the United States Northeast, are both manifestations of the ... is creating changes in the atmosphere’s “energy balance,” according ... NASA researcher, speaking on the Sharon Kleyne Hour™ Power ... a warmer and dryer global climate but also greater ...
(Date:3/27/2015)... To address their number one lawn care question ... filming this video to explain the complicated dynamics between the ... often expected to thrive in, be it in dense building ... survive. Anytime a sun-loving plant is put in the shade ... homeowners try to amend this issue by applying large quantities ...
Breaking Medicine News(10 mins):Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... Va. The National Institute of Dental and Craniofacial ... (AADR) a multi-year Bloc Travel Grant in the amount ... Each year, this award will assist approximately 50 students ... Dental Research (IADR) General Session & Exhibition for the ...
... With the nation,s economic crisis contributing to greater workplace ... be more important than ever. , Unfortunately, the approach ... is flawed and unlikely to produce the best outcomes ... according to a Florida State University College of Medicine ...
... "Despite our concerns about the ill-advised proposal to ... by the VA for service-connected health conditions, Vietnam ... President Obama for its generosity in assisting all ... President John Rowan. "VVA joins fellow veterans, service ...
... IRVINE, Calif., March 17 Frost & Sullivan ... in the Global Diabetes Diagnostics Market to Epinex for ... . Frost & Sullivan is an internationally renowned market ... years of history in the global marketplace. The ...
... March 17 Shands HealthCare has selected the ... key component of its ongoing effort to improve ... healthcare system affiliated with the University of ... in Gainesville and Jacksonville. It includes eight Shands ...
... largest water efficiency conference Oct. 7-9 in Las Vegas , ... Denver ... water resources, the American Water Works Association (AWWA), the authoritative ... WaterSmart Innovations Conference and Exposition , Oct. 7-9, 2009, in Las Vegas., ...
Cached Medicine News:Health News:Researcher wins $2.6 million grant for depression care study 2Health News:Researcher wins $2.6 million grant for depression care study 3Health News:VVA Praises President's Budget Submission for Veterans Affairs; Condemns Ill-advised Revenue Proposal 2Health News:Frost and Sullivan Picks Epinex for Diabetes Research Award 2Health News:Shands HealthCare Selects Micromedex CareNotes System from Thomson Reuters to Improve Patient Education 2Health News:Shands HealthCare Selects Micromedex CareNotes System from Thomson Reuters to Improve Patient Education 3Health News:AWWA partners with WaterSmart Innovations conference 2
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
... for LASIK surgery and other types ... the corneal interface and/or stromal bed. ... the flap and helps elevate the ... irrigation.27G x 7/8in (.40 x 22mm) ...
... surgery and other types of refractive surgery. ... stromal bed. Flattened tip provides easy insertion ... flap edge. Multiple ports provide multi-directional irrigation. ... 9mm from end tip flattened 1.5mm from ...
Medicine Products: